PepsiCo (PEP) CEO Ramon Laguarta said GLP-1 drugs for weight loss and diabetes, such as Ozempic, Wegovy, and Mounjaro, aren't yet having an effect on the business. In the company's second quarter ...

PepsiCo (PEP) CEO Ramon Laguarta sits down with Yahoo Finance ... "I am hopeful that the current administration will help us close some of the big wars that we have today in the world ...

Beverage and snack maker PepsiCo (PEP) is taking a cautious approach to the next 12 months due to concerns over tariffs and intense competition. CEO Ramon Laguarta told Yahoo Finance that the ...

PepsiCo (PEP) CEO Ramon Laguarta sits down with Yahoo Finance Executive Editor Brian Sozzi at the World Economic Forum in Davos, Switzerland, to discuss the impact of US President Donald Trump's ...

PepsiCo (PEP) CEO Ramon Laguarta said GLP-1 drugs for weight loss and diabetes, such as Ozempic, Wegovy, and Mounjaro, aren't yet having an effect on the business. In the company's second quarter ...